Alliant Credit Union mortgage review 2026: 0%-Down, no-PMI loans for first-time buyers and physicians

Alliant offers three zero-down mortgage options (Alliant Advantage, VA and physician loans) and its 30-year fixed was as low as 6.38% on March 12 — roughly 3 basis points above the Mortgage News Daily average of 6.35%. Membership requires a $5 donation (Alliant covers the fee) and the lender operates in all U.S. states and D.C. except Maryland; product set includes conventional, FHA, USDA, VA, jumbo, physician, construction, refinance and HELOCs (HELOC minimum $10,000). Key benefits are no PMI on its zero-down/physician loans and cash-back rewards up to $9,500 via a realtor partnership; drawbacks are higher-than-average rates for a credit union, limited mortgage-specific customer service hours, and the requirement to join before applying.

Analysis

Alliant’s product mix functionally re-shapes who holds early-cycle mortgage credit exposure: when originators keep more first-loss economics (via lender-retained no-PMI programs), the marginal demand for third-party private mortgage insurance shrinks and more credit stucks into bank/credit-union balance sheets or non-agency pools. That flow increases funding and capital intensity for originators and broadens the universe of loans that don’t clear through standard agency wrappers, which in turn raises volatility and liquidity risk in non-agency conduits over a 3–18 month window.

Interest-rate direction is the dominant near-term catalyst. If rates grind higher from here, originators who priced to win market share while keeping credit risk will suffer mark-to-market pressure on warehouse lines and see underwriting margin compression within one quarter. Conversely, if rates fall meaningfully, these programs can expand share quickly and impose asymmetric losses on PMI vendors and holders of low-credit-quality, short-duration paper.

The market is underestimating two second-order dynamics: (1) pricing signals. A lender charging a premium despite offering credit-bearing products implies intentional risk retention rather than a deposit-cost advantage — that means credit performance expectations, not distribution, drive pricing; (2) segmentation of demand. Growth will be concentrated in specific borrower cohorts and price bands, so impacts on homebuilders, agencies, and insurers will be lumpy and location-dependent rather than uniform nationwide over the next 6–24 months.

Key Decisions for Investors

• Pair trade (6–12 months): Long entry-level homebuilder DHI, short mortgage insurer RDN — rationale: upside from incremental purchase demand concentrated at lower price points, offset by potential volume pressure on private mortgage insurers. Position size: 60% long DHI / 40% short RDN. Risk/reward: target +20% net return if new-buyer share rises; stop-loss at -12% on the pair if 30yr rates >7.25%.
• Relative-value in housing finance (3–9 months): Long agency MBS REIT AGNC with a 6–month horizon, financed with a tight-duration hedge (short 2yr futures) to reduce rate-blowout risk. Risk/reward: capture 6–8% carry annualized vs downside on spread blowouts; hedge with a 3–5% budget for protective puts if spread widens >150bps.
• Event-driven short (3–6 months): Initiate a modest short on smaller PMI/credit supplement names (MTG) sized for portfolio beta exposure — thesis is structural margin erosion for standalone PMI if originators push retained-risk products. Risk management: cap exposure to 1–2% NAV; expect limited upside if market-share shift proves incremental rather than transformational.
• Opportunistic options (1–3 months): Buy put spreads on broad mortgage originator RKT expiring 3–6 months out to express risk of warehouse funding stress and reduced origination volumes if rates stay elevated. Cost-control: use debit spreads to cap premium; target asymmetric payoff of 3–4x premium if origination volumes drop >15% quarter-over-quarter.